Insider trades

Takashi Kei Kishimoto, Chief Officer of Cartesian Therapeutics RNAC, has filed 0 purchases and 4 sales on the open market. The latest trade was on 23/05/31.

Takashi Kei Kishimoto

Chief Scientific Officer
First filing
23/01/06
Trades
10 trades
Buys / sales
0 / 4
12-month net buying
No record
Last trade
23/05/31

Trading activity

Transactions

Trade type
RNAC
Open-market sale23/01/04–23/01/0523/01/069,784 sh4 trades$1.13avg.$11,055.74−2.6%